Indication

To improve wakefulness and reduce excessive daytime sleepiness (EDS) in adult patients with narcolepsy (with or without cataplexy).

Medicine details

Medicine name:
solriamfetol (Sunosi)
SMC ID:
SMC2439
Pharmaceutical company
Jazz Pharmaceuticals
BNF chapter
Central nervous system
Submission type
Full
Publication due date:
11 July 2022
SMC meeting date:
07 June 2022
Patient group submission deadline:
04 April 2022